ArticleThe Journal of clinical investigation2016

A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.

Rudy E Fuentes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.